Ruben Mesa

nobleid.org/rubenmesa

Myeloproliferative Neoplasms: Diagnosis and Treatment Acute Myeloid Leukemia Research Chronic Lymphocytic Leukemia Research Platelet Disorders and Treatments Hematological disorders and diagnostics

Created: Nov 9, 2026

•Updated: Nov 9, 2026

Public URLs (2)

https://nobleid.org/NI4P84W74R94S52 https://nobleid.org/rubenmesa

Affiliations

Mays Cancer Center at UT Health San Antonio

2023 - Present

Wake Forest Baptist Comprehensive Cancer Center

2023 - Present

Atrium Health Wake Forest Baptist

2023 - Present

Wake Forest University Health Sciences

2023 - Present

Levine Cancer Institute

2023 - Present

Cited by

Measure	All
Citations	46,322
h-index	99
i10-index	447

As of Oct 14, 2026 · 1,284 works

Works (1,161)

1,083 on NobleID · 78 being added

Title	Cited by	Year
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell	2,997	2005
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis New England Journal of Medicine	2,097	2012
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study The Lancet	1,725	2020
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment Blood	1,255	2008
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis New England Journal of Medicine	1,164	2010

Sign in to see the full profile

Creating an account is free.

Create an account

For data access, contact info@nobleid.org.